25.3.2020 New Council of Europe resolution will promote pharmaceutical care in Europe

20.3.2020 Rational use of medicines is promoted through the activities of the National Medicines Information Network

19.3.2020 Clinical trials during the coronavirus epidemic (COVID-19)

16.3.2020 Marketing ban decision for Novartis Finland Oy concerning practices in violation of the Medicines Act related to the treatment of outpatient care patients at a medical centre

16.3.2020 Fimea advises against overstocking medicine

24.2.2020 Emerade adrenaline pens recalled from consumers

5.2.2020 Fimea has switched to electronic signatures for marketing authorisation decisions

4.2.2020 The SNSA pilot starts

17.1.2020 Fimea Helsinki office has moved to new premises at Tilkanmäki

8.1.2020 New decree on fees chargeable by the Finnish Medicines Agency entered into force on 1 January 2020